PhaseBio Pharmaceuticals, Inc. (PHAS)
Other Income/Expenses (Net)
$13.15M
TTM · Period ending: · USD
PHAS Other Income/Expenses (Net)
Latest reported$13.15Mperiod ending
Latest reported$13.15Mperiod ending
PHAS Other Income/Expenses (Net) ($281.00K → $13.15M)
Annual Other Income/Expenses (Net)
High-resolution chart · PNG
PHAS other income/expenses (net) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 947 | |
| -13,709,000 | |
| 489,000 | |
| -4,202,000 | |
| -1,709,000 | |
| 281,000 |